No Data
No Data
IVD Medical completed the placement of a total of 0.271 billion shares of Placement Shares.
IVD Medical (01931) announced that the preconditions of the placement agreement have been met and the placement was completed on July 24, 2024. A total of 0.271 billion shares were sold at a placement price of HKD 0.7 per share to no less than six underwriters (equivalent to approximately 16.67% of the company's enlarged issued share capital after the completion of the placement).
IVD Medical Holding Completes Major Share Placement
Ivd medical (01931.HK) completed the placement of a total of 0.271 billion shares.
On July 24, Gelonhui announced that the prerequisite for the placement agreement had been met, and the placement was completed on July 24, 2024. A total of 0.271 billion shares were placed (equivalent to approximately 16.67% of the expanded issued share capital after the placement) at a placement price of HKD 0.7 per share to no less than six placing agents. The total amount of funds raised from the placement was approximately HKD 189.6 million, with net proceeds of approximately HKD 189.1 million.
Saphetor SA Receives IVDR Certification for Clinical Diagnosis Support NGS Data Analysis Platform, VarSome Clinical, Ensuring Enhanced Safety and Performance Standards
Investors Don't See Light At End Of IVD Medical Holding Limited's (HKG:1931) Tunnel And Push Stock Down 28%
Ivd Medical (01931): Lin Huiyin resigns as joint company secretary and authorized representative.
IVD Medical (01931) announced that Lin Huiyin has resigned as the joint company secretary of the company and the director of the Stock Exchange's listing rules...
No Data